In general, this study suggests that erenumab has a more consistent effect on increase in blood pressure than fremanezumab; however, this does show that CGRP mabs may result in increases in blood pressure and potentially new onset hypertension in a subset of patients (44). Here, CALCA is linked to Hypertension.